ES8704736A1 - Procedimiento para la obtencion de una composicion farmaceutica conteniendo un agente fibrino litico y un factor de difusion, util para el tratamiento del infarto de miocardio. - Google Patents

Procedimiento para la obtencion de una composicion farmaceutica conteniendo un agente fibrino litico y un factor de difusion, util para el tratamiento del infarto de miocardio.

Info

Publication number
ES8704736A1
ES8704736A1 ES526300A ES526300A ES8704736A1 ES 8704736 A1 ES8704736 A1 ES 8704736A1 ES 526300 A ES526300 A ES 526300A ES 526300 A ES526300 A ES 526300A ES 8704736 A1 ES8704736 A1 ES 8704736A1
Authority
ES
Spain
Prior art keywords
useful
treatment
myocardial infarction
agent
litical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES526300A
Other languages
English (en)
Spanish (es)
Other versions
ES526300A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Serono SpA
Original Assignee
Istituto Farmacologico Serono SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Farmacologico Serono SpA filed Critical Istituto Farmacologico Serono SpA
Publication of ES8704736A1 publication Critical patent/ES8704736A1/es
Publication of ES526300A0 publication Critical patent/ES526300A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
ES526300A 1982-10-08 1983-10-06 Procedimiento para la obtencion de una composicion farmaceutica conteniendo un agente fibrino litico y un factor de difusion, util para el tratamiento del infarto de miocardio. Expired ES8704736A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT49241/82A IT1189379B (it) 1982-10-08 1982-10-08 Composizione farmaceutica contenente un agente fibrinolitico ed un fattore di diffusione,utile per il trattamento dell'infarto miocardico

Publications (2)

Publication Number Publication Date
ES8704736A1 true ES8704736A1 (es) 1987-05-01
ES526300A0 ES526300A0 (es) 1987-05-01

Family

ID=11270058

Family Applications (1)

Application Number Title Priority Date Filing Date
ES526300A Expired ES8704736A1 (es) 1982-10-08 1983-10-06 Procedimiento para la obtencion de una composicion farmaceutica conteniendo un agente fibrino litico y un factor de difusion, util para el tratamiento del infarto de miocardio.

Country Status (12)

Country Link
US (1) US4568543A (OSRAM)
EP (1) EP0106812B1 (OSRAM)
JP (1) JPS5989630A (OSRAM)
AT (1) ATE44467T1 (OSRAM)
AU (1) AU559192B2 (OSRAM)
CA (1) CA1217717A (OSRAM)
DE (2) DE106812T1 (OSRAM)
DK (1) DK161564C (OSRAM)
ES (1) ES8704736A1 (OSRAM)
IL (1) IL69938A (OSRAM)
IT (1) IT1189379B (OSRAM)
ZA (1) ZA837484B (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5275812A (en) * 1985-06-07 1994-01-04 The General Hospital Corporation Method of treatment for myocardial infarction
US5279824A (en) * 1988-04-14 1994-01-18 Merck Patent Gmbh Pharmaceutical formulation containing heparin and endo-beta-glucuronidase, useful for the treatment of thrombosis
DK0456724T3 (da) * 1989-01-27 1995-10-02 Immunolytics Inc Præparat og fremgangsmåde til behandling af benign prostatisk hypertrofi
CA2027936C (en) 1989-10-23 2001-07-24 Smithkline Beecham Corporation Cyclic anti-aggregatory peptides
US5939412A (en) * 1992-06-26 1999-08-17 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
EP0794779A4 (en) * 1994-12-22 1998-04-29 Smithkline Beecham Corp FIBRINOGENIC RECEPTOR ANTAGONISTS
AU2003220115A1 (en) * 2002-05-20 2003-12-12 Board Of Regents, The University Of Texas System Methods and compositions for delivering enzymes and nucleic acid molecules to brain, bone, and other tissues
US7220407B2 (en) * 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1179787A (en) * 1967-03-22 1970-01-28 Biorex Laboratories Ltd Stabilised and Potentiated Therapeutic Enzyme Compositions
US3708575A (en) * 1970-05-13 1973-01-02 Biorex Laboratories Ltd Method for the treatment of atherosclerosis employing glucuronoglycos-aminoglycan-hyaluronate-lyase
US4271150A (en) * 1979-03-07 1981-06-02 Zeria-Shinyaku Kogyo Kabushiki Kaisha Urokinase preparation for oral administration

Also Published As

Publication number Publication date
DK464483D0 (da) 1983-10-07
IL69938A0 (en) 1984-01-31
EP0106812A3 (en) 1985-09-11
US4568543A (en) 1986-02-04
ZA837484B (en) 1984-06-27
DE3380166D1 (en) 1989-08-17
EP0106812A2 (en) 1984-04-25
IL69938A (en) 1987-09-16
EP0106812B1 (en) 1989-07-12
AU1988383A (en) 1984-04-12
CA1217717A (en) 1987-02-10
ATE44467T1 (de) 1989-07-15
IT8249241A1 (it) 1984-04-08
DK464483A (da) 1984-04-09
DK161564C (da) 1992-01-06
DK161564B (da) 1991-07-22
ES526300A0 (es) 1987-05-01
DE106812T1 (de) 1984-08-30
JPS5989630A (ja) 1984-05-23
IT1189379B (it) 1988-02-04
AU559192B2 (en) 1987-02-26
JPS6150927B2 (OSRAM) 1986-11-06
IT8249241A0 (it) 1982-10-08

Similar Documents

Publication Publication Date Title
ES2039480T3 (es) Una forma de dosificacion liquida para administracion oral de una sustancia farmaceuticamente activa.
MY101791A (en) New benzimidazole derivatives
NO895112D0 (no) Kosmetisk blanding.
ES8600060A1 (es) Procedimiento para preparar un medicamento envasado que contiene como sustancia activa un antagonista del calcio tal como nifedipina, verapamil diltiazem y otros.
GR3007385T3 (OSRAM)
ES8206180A1 (es) Un metodo para producir una composicion farmaceutica solida de un medicamento en microdosis.
NO971356L (no) Terapeutisk vitamin-kalsium-blanding i enhetlig galenisk tablettform, fremgangsmåte for fremstilling av samme og anvendelse derav
EP0137542A3 (en) Pharmaceutical composition for the treatment of states of acute renal insufficiency
DK154537C (da) Hurtig-disintegrerende komprimerede laegemiddelpraeparater
ES8704736A1 (es) Procedimiento para la obtencion de una composicion farmaceutica conteniendo un agente fibrino litico y un factor de difusion, util para el tratamiento del infarto de miocardio.
PT76247B (en) Process for preparing antiinflammatory and/or analgesic 2,3-diaryl-5-halo thiophenes and of pharmaceutical compositions containing the same
ES2051809T3 (es) Un procedimiento para preparar una composicion farmaceutica.
DE2963545D1 (en) Pharmaceutical composition containing all-e- or 13-z-7,8-dehydro-retinoic acid and process for its preparation
ES8605261A1 (es) Un procedimiento para la preparacion de 1,4-aminoalquilamino-9-h-tioxaten-9-onas.
ES2039194T3 (es) Un metodo de preparar una composicion farmaceutica tromboliticamente activa.
EP0182277A3 (en) Pyrazine diazohydroxide compounds and methods for their production and use
FR2260995A1 (en) Benzimidazole-contg. medicaments - for treating non-malignant gastroduodenal disorders, esp. ulcers and hypersecretion
GB1449441A (en) Agnets for lowering the lipid level in plasma
SU1166370A1 (ru) Антигельминтное средство
BG52067B2 (en) Antihypoxic and brain-protection antidote composition
GB1279686A (en) Pharmaceutical composition and mental illness treatment pack
FR2088115A1 (en) Herbicide for use in beet crops
NL7004070A (en) Herbicide for use in beet crops
GB1317054A (en) Graphite electrodes
JPS6429320A (en) Drug composition

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20060120